185 results on '"Michelini, Zuleika"'
Search Results
2. Safety and efficiency modifications of SIV-based integrase-defective lentiviral vectors for immunization
3. Anti-Tumor Immunity to Patient-Derived Breast Cancer Cells by Vaccination with Interferon-Alpha-Conditioned Dendritic Cells (IFN-DC).
4. Development and Preclinical Evaluation of an Integrase Defective Lentiviral Vector Vaccine Expressing the HIVACAT T Cell Immunogen in Mice
5. Endogenous CCL2 neutralization restricts HIV-1 replication in primary human macrophages by inhibiting viral DNA accumulation
6. SARS-CoV-2-Specific CD8+ T-Cells in Blood but Not in the Lungs of Vaccinated K18-hACE2 Mice after Infection
7. Functionalized gold nanorods as drug carriers: a promising antiviral system
8. The induction of SARS-CoV-2-specific CD8+ T cell immunity uncouples with the viral spread in K18-hACE2 infected mice
9. Different configurations of SARS-CoV-2 spike protein delivered by integrase-defective lentiviral vectors induce persistent functional immune responses, characterized by distinct immunogenicity profiles
10. New Monoclonal Antibodies Specific for Different Epitopes of the Spike Protein of SARS-CoV-2 and Its Major Variants: Additional Tools for a More Specific COVID-19 Diagnosis
11. Induction of SARS-CoV-2 N-specific CD8+ T cell immunity in lungs by engineered extracellular vesicles associates with strongly impaired viral replication
12. Induction of SARS-CoV-2 N-specific CD8+T cell immunity in lungs by engineered extracellular vesicles associates with strongly impaired viral replication
13. SARS-CoV-2-Specific CD8 + T-Cells in Blood but Not in the Lungs of Vaccinated K18-hACE2 Mice after Infection.
14. IDLV-HIV-1 Env vaccination in non-human primates induces affinity maturation of antigen-specific memory B cells
15. Antiviral effect of SARS-CoV-2 N-specific CD8+ T cells induced in lungs by engineered extracellular vesicles.
16. Strong SARS-CoV-2 N-Specific CD8+ T Immunity Induced by Engineered Extracellular Vesicles Associates with Protection from Lethal Infection in Mice
17. UltraViolet SANitizing System for Sterilization of Ambulances Fleets and for Real-Time Monitoring of Their Sterilization Level
18. Isolation and Characterization of Mouse Monoclonal Antibodies That Neutralize SARS-CoV-2 and Its Variants of Concern Alpha, Beta, Gamma and Delta by Binding Conformational Epitopes of Glycosylated RBD With High Potency
19. Persistent Immunogenicity of Integrase Defective Lentiviral Vectors delivering membrane tethered Native-Like HIV-1 Envelope Trimers
20. Development and use of SIV-based Integrase defective lentiviral vector for immunization
21. Successful Immunization with a Single Injection of Non-integrating Lentiviral Vector
22. Integrase-Defective Lentiviral Vector Is an Efficient Vaccine Platform for Cancer Immunotherapy
23. Integrase Defective, Nonintegrating Lentiviral Vectors
24. Integrase-Defective Lentiviral Vectors for Delivery of Monoclonal Antibodies against Influenza
25. Toward Integrase Defective Lentiviral Vectors for Genetic Immunization
26. Macaca mulatta, fascicularis and nemestrina in AIDS vaccine development
27. PROTECTION AGAINST AIDS IN TAT-PROTEIN VACCIN- ATED MONKEYS AFTER RECHALLENGE WITH A HIGH DOSE OF SHIV89·6PCY243 IN THE ABSENCE OF DETECT- ABLE ANTI-ENV AND ANTI-GAG ANTIBODIES AND ANTI- GAG CELLULAR RESPONSES: ABSTRACT #121
28. LONG-TERM EFFICACY OF A CANDIDATE T-CELL HIV/ AIDS MULTIPROTEIN VACCINE FOLLOWING MUCOSAL CHALLENGE WITH SIVMAC251 IN CYNOMOLGUS MON- KEYS: ABSTRACT #117
29. Long-term protection against SHIV89.6P replication in HIV-1 Tat vaccinated cynomolgus monkeys
30. T-cell-mediated protective efficacy of a systemic vaccine approach in cynomolgus monkeys after SIV mucosal challenge
31. Effect of vaccination with recombinant modified vaccinia virus Ankara expressing structural and regulatory genes of SIVmacJ5 on the kinetics of SIV replication in cynomolgus monkeys
32. SHIV89.6P pathogenicity in cynomolgus monkeys and control of viral replication and disease onset by human immunodeficiency virus type 1 Tat vaccine
33. Simian immunodeficiency virus-Vpx for improving integrase defective lentiviral vector-based vaccines
34. Integrase defective lentiviral vector as a vaccine platform for delivering Influenza antigens
35. Vaccination with DNA containing tat coding sequences and unmethylated CpG motifs protects cynomolgus monkeys upon infection with simian/human immunodeficiency virus (SHIV89.6P)
36. Microbial translocation and T cell activation are modified by direct-acting antiviral therapy in HCV-infected patients
37. Integrase Defective Lentiviral Vector as a Vaccine Platform for Delivering Influenza Antigens
38. Long-Lasting Protection by Live Attenuated Simian Immunodeficiency Virus in Cynomolgus Monkeys: No Detection of Reactivation after Stimulation with a Recall Antigen
39. Intranasal Administration of Integrase Defective Lentiviral Vectors Expressing mAbs Protects from H5 Influenza Virus Challenge In Vivo
40. HIV‐1 DNA dynamics and variations in HIV‐1 DNA protease and reverse transcriptase sequences in multidrug‐resistant patients during successful raltegravir‐based therapy
41. Reduced Plasma Levels of sCD14 and I-FABP in HIV-infected Patients with Mesalazine-treated Ulcerative Colitis
42. Erratum to: Endogenous CCL2 neutralization restricts HIV-1 replication in primary human macrophages by inhibiting viral DNA accumulation
43. Evaluation of HIV-1 integrase inhibitors on human primary macrophages using a luciferase-based single-cycle phenotypic assay
44. Murine Granulocyte–Macrophage Colony-Stimulating Factor Expressed from a Bicistronic Simian Immunodeficiency Virus-Based Integrase-Defective Lentiviral Vector Does Not Enhance T-Cell Responses in Mice
45. Biocompatible Anionic Polymeric Microspheres as Priming Delivery System for Effetive HIV/AIDS Tat-Based Vaccines
46. Optimization of Mucosal Responses after Intramuscular Immunization with Integrase Defective Lentiviral Vector
47. Mucosal Immunization with Integrase-Defective Lentiviral Vectors Protects against Influenza Virus Challenge in Mice
48. Effects of Raltegravir on 2-Long Terminal Repeat Circle Junctions in HIV Type 1 Viremic and Aviremic Patients
49. Integrase-defective lentiviral-vector-based vaccine: a new vector for induction of T cell immunity
50. Transduction of Human Antigen-Presenting Cells with Integrase-Defective Lentiviral Vector Enables Functional Expansion of Primed Antigen-Specific CD8+ T Cells
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.